RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 95 filers reported holding RA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $14,439,000 | -16.1% | 300,745 | -18.0% | 0.01% | +7.7% |
| Q4 2019 | $17,216,000 | +163.9% | 366,845 | +26.0% | 0.01% | +116.7% |
| Q1 2019 | $6,523,000 | +86.7% | 291,200 | +51.7% | 0.01% | +50.0% |
| Q4 2018 | $3,493,000 | +32.4% | 191,900 | +31.6% | 0.00% | +33.3% |
| Q3 2018 | $2,638,000 | +63.3% | 145,800 | -40.5% | 0.00% | +200.0% |
| Q2 2018 | $1,615,000 | +71.3% | 245,000 | +38.0% | 0.00% | 0.0% |
| Q1 2018 | $943,000 | – | 177,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,031,562 | $17,268,000 | 2.42% |
| NEA Management Company, LLC | 3,493,636 | $29,696,000 | 1.23% |
| VHCP Management II, LLC | 544,612 | $4,629,000 | 1.11% |
| RA Capital Management | 1,351,808 | $11,490,000 | 0.96% |
| Rock Springs Capital Management LP | 600,000 | $5,100,000 | 0.23% |
| Rhenman & Partners Asset Management AB | 108,451 | $922,000 | 0.12% |
| Tekla Capital Management LLC | 356,237 | $3,028,000 | 0.12% |
| ELLINGTON MANAGEMENT GROUP LLC | 34,900 | $297,000 | 0.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 79,150 | $673,000 | 0.03% |
| Candriam S.C.A. | 151,000 | $1,284,000 | 0.02% |